Literature DB >> 26097999

The role of iNOS in cholesterol-induced liver fibrosis.

Sarit Anavi1, Michal Eisenberg-Bord1, Michal Hahn-Obercyger1, Olga Genin2, Mark Pines2, Oren Tirosh1.   

Abstract

Accumulation of cholesterol in the liver is associated with the development of non-alcoholic steatohepatitis-related fibrosis. However, underlying mechanisms are not well understood. The present study investigated the role of inducible nitric oxide synthase (iNOS) in cholesterol-induced liver fibrosis by feeding wild-type (WT) and iNOS-deficient mice with control or high-cholesterol diet (HCD) for 6 weeks. WT mice fed with HCD developed greater liver fibrosis, compared with iNOS-deficient mice, as evident by Sirius red staining and higher expression levels of profibrotic genes. Enhanced liver fibrosis in the presence of iNOS was associated with hypoxia-inducible factor-1α stabilization, matrix metalloproteinase-9 expression, and enhanced hepatic DNA damage. The profibrotic role of iNOS was also demonstrated in vivo using a selective inhibitor of iNOS as well as in vitro in a rat liver stellate cell line (HSC-T6). In conclusion, these findings suggest that iNOS is an important mediator in HCD-induced liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26097999     DOI: 10.1038/labinvest.2015.67

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  64 in total

1.  Cell cycle protein profile of the hepatic stellate cells(HSCs)in dimethylnitrosamine-induced rat hepatic fibrosis.

Authors:  Mi-Rhan Kim; Han-Seong Kim; Mi Sook Lee; Min-Jae Lee; Ja-June Jang
Journal:  Exp Mol Med       Date:  2005-08-31       Impact factor: 8.718

2.  Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet.

Authors:  Yi Chen; Shigenari Hozawa; Sadaaki Sawamura; Shinkichi Sato; Naoto Fukuyama; Chizuko Tsuji; Tetsuya Mine; Yasunori Okada; Ryuzaburo Tanino; Yoichi Ogushi; Hiroe Nakazawa
Journal:  Biochem Biophys Res Commun       Date:  2005-01-07       Impact factor: 3.575

3.  Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C.

Authors:  Victoria L Gadd; Michelle Melino; Sandrine Roy; Leigh Horsfall; Peter O'Rourke; Millicent R Williams; Katharine M Irvine; Matthew J Sweet; Julie R Jonsson; Andrew D Clouston; Elizabeth E Powell
Journal:  Liver Int       Date:  2012-12-13       Impact factor: 5.828

4.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

5.  Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.

Authors:  Jeon-Ok Moon; Timothy P Welch; Frank J Gonzalez; Bryan L Copple
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-08       Impact factor: 4.052

6.  Repair of nitric oxide-damaged DNA in beta-cells requires JNK-dependent GADD45alpha expression.

Authors:  Katherine J Hughes; Gordon P Meares; Kari T Chambers; John A Corbett
Journal:  J Biol Chem       Date:  2009-08-02       Impact factor: 5.157

7.  Interleukin-1 participates in the progression from liver injury to fibrosis.

Authors:  Roben G Gieling; Karen Wallace; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

8.  Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.

Authors:  H-Y Yue; C Yin; J-L Hou; X Zeng; Y-X Chen; W Zhong; P-F Hu; X Deng; Y-X Tan; J-P Zhang; B-F Ning; J Shi; X Zhang; H-Y Wang; Y Lin; W-F Xie
Journal:  Gut       Date:  2009-08-10       Impact factor: 23.059

Review 9.  Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.

Authors:  Mariko Murata; Raynoo Thanan; Ning Ma; Shosuke Kawanishi
Journal:  J Biomed Biotechnol       Date:  2012-01-26

10.  Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.

Authors:  Wei Wang; Caiyan Zhao; Junying Zhou; Zhen Zhen; Yadong Wang; Chuan Shen
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  22 in total

1.  Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.

Authors:  Chofit Chai; Bryan Cox; Dayana Yaish; Devora Gross; Nofar Rosenberg; Franck Amblard; Zohar Shemuelian; Maytal Gefen; Amit Korach; Oren Tirosh; Tali Lanton; Henrike Link; Joseph Tam; Anna Permyakova; Gunes Ozhan; Jonathan Citrin; Haixing Liao; Mirna Tannous; Michal Hahn; Jonathan Axelrod; Enara Arretxe; Cristina Alonso; Ibon Martinez-Arranz; Pablo Ortiz Betés; Rifaat Safadi; Ahmad Salhab; Johnny Amer; Zahira Tber; Seema Mengshetti; Hilla Giladi; Raymond F Schinazi; Eithan Galun
Journal:  Gastroenterology       Date:  2020-05-22       Impact factor: 22.682

2.  SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling.

Authors:  Yanhuan Feng; Jun Xu; Fan Guo; Rongshuang Huang; Min Shi; Lingzhi Li; Liang Ma; Ping Fu
Journal:  RSC Adv       Date:  2018-02-06       Impact factor: 4.036

3.  Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis.

Authors:  Resat Cinar; Malliga R Iyer; Ziyi Liu; Zongxian Cao; Tony Jourdan; Katalin Erdelyi; Grzegorz Godlewski; Gergő Szanda; Jie Liu; Joshua K Park; Bani Mukhopadhyay; Avi Z Rosenberg; Jeih-San Liow; Robin G Lorenz; Pal Pacher; Robert B Innis; George Kunos
Journal:  JCI Insight       Date:  2016-07-21

Review 4.  Danger signals in liver injury and restoration of homeostasis.

Authors:  Hui Han; Romain Desert; Sukanta Das; Zhuolun Song; Dipti Athavale; Xiaodong Ge; Natalia Nieto
Journal:  J Hepatol       Date:  2020-05-01       Impact factor: 25.083

5.  Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis.

Authors:  Mohamed A Abdelmegeed; Youngshim Choi; Grzegorz Godlewski; Seung-Kwon Ha; Atrayee Banerjee; Sehwan Jang; Byoung-Joon Song
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

6.  Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis.

Authors:  Yula Kaminsky-Kolesnikov; Einat Rauchbach; Diana Abu-Halaka; Michal Hahn; Carmen García-Ruiz; Jose C Fernandez-Checa; Zecharia Madar; Oren Tirosh
Journal:  Oxid Med Cell Longev       Date:  2020-05-25       Impact factor: 6.543

Review 7.  Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.

Authors:  Mishghan Zehra; James C Curry; Sneha S Pillai; Hari Vishal Lakhani; Cory E Edwards; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

Review 8.  Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease.

Authors:  Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  J Dev Orig Health Dis       Date:  2020-04-15       Impact factor: 2.401

Review 9.  Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase.

Authors:  Yasuko Iwakiri
Journal:  Clin Mol Hepatol       Date:  2015-12-24

10.  Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.

Authors:  Haruka Mizobuchi; Wataru Fujii; Shoko Isokawa; Kanna Ishizuka; Yihan Wang; Sayoko Watanabe; Chizu Sanjoba; Yoshitsugu Matsumoto; Yasuyuki Goto
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.